Takeda Pharmaceutical Company Limited Share Price Börse Stuttgart
Equities
TKD
JP3463000004
Pharmaceuticals
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.88 EUR | -0.06% | +4.05% | -3.56% |
06-06 | Former Takeda Employee Pleads Guilty to Defrauding Company | DJ |
06-06 | Takeda Pharmaceutical Unit Partners with HEALWELL AI for Real-World Evidence Analysis of Hereditary Angioedema | MT |
Sales 2024 | 4,264B 27.45B 25.22B 2,147B | Sales 2025 * | 4,252B 27.38B 25.14B 2,140B | Capitalization | 6,594B 42.46B 39B 3,320B |
---|---|---|---|---|---|
Net income 2024 | 144B 928M 852M 72.53B | Net income 2025 * | 116B 750M 689M 58.62B | EV / Sales 2024 | 1.54 x |
Net Debt 2024 * | 3,771B 24.28B 22.3B 1,898B | Net Debt 2025 * | 4,224B 27.2B 24.98B 2,127B | EV / Sales 2025 * | 2.54 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
59.6
x | Employees | - |
Yield 2024 |
4.49% | Yield 2025 * |
4.61% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 week | +4.05% | ||
Current month | +2.26% | ||
1 month | +1.30% | ||
3 months | -6.50% | ||
6 months | -3.75% | ||
Current year | -3.56% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 31/03/14 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 31/01/22 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 31/12/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 31/05/16 | |
Ian Clark
BRD | Director/Board Member | 62 | 31/12/18 |
Steven Gillis
BRD | Director/Board Member | 71 | 31/12/18 |
Date | Price | Change |
---|---|---|
07/06/24 | 24.79 | -0.44% |
06/06/24 | 24.9 | -0.08% |
05/06/24 | 24.92 | +2.34% |
04/06/24 | 24.35 | -0.16% |
03/06/24 | 24.39 | +0.16% |
Delayed Quote Börse Stuttgart, June 07, 2024 at 07:15 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.64% | 754B | |
+39.48% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
+11.61% | 217B | |
-1.96% | 216B | |
+0.03% | 163B | |
+6.13% | 164B |
- Stock Market
- Equities
- 4502 Stock
- TKD Stock